Stay updated on Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Related topics now omit 'Prostate cancer' and 'MedlinePlus Genetics'. This removes disease context and linked educational resources from the page.
    Difference
    0.2%
    Check dated 2026-01-21T00:01:33.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Minor changes include addition of related topics such as Prostate cancer and MedlinePlus Genetics, and a revision label update to v3.3.4 (replacing v3.3.3). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-14T00:47:24.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Footer now displays Revision: v3.3.3, replacing the previous Revision: v3.3.2 and removing the HHS Vulnerability Disclosure entry.
    Difference
    0.1%
    Check dated 2025-12-23T08:43:49.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2, and the Revision: v3.3.1 note has been removed. This appears to be a minor site version update with no impact on the study details, eligibility criteria, or user-facing content.
    Difference
    0.1%
    Check dated 2025-12-01T16:38:08.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    A new revision label 'Revision: v3.3.1' has been added. Related topics including 'Prostate cancer', 'MedlinePlus Genetics', and 'Revision: v3.2.0' have been removed.
    Difference
    0.2%
    Check dated 2025-11-24T12:42:38.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Added Prostate cancer and MedlinePlus Genetics as related topics. Removed the government funding status notice regarding NIH operations (the NIH Clinical Center).
    Difference
    0.6%
    Check dated 2025-11-17T06:24:06.000Z thumbnail image

Stay in the know with updates to Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Immunogenic Nivolumab + Ipilimumab in Prostate Cancer Clinical Trial page.